Asonor® is developed by leading pharmaceutical manufacturers and scientists in the Netherlands, Germany and Denmark.

Asonor®’s effect on snoring is clinically proven and was in 2005 registered by the health authorities in EU, in accordance with the requirements of the Directive 93/42/EEC. The classification and the documentation of the safety and effect against snoring is fully comply with Directive 93/42/EEC.

This means that the Health Authorities in Europe have approved that Asonor® fulfills:

  • the demands for documentation in relation to the product classification
  • the safety related requirements
  • the mentioned effect

The registered and approved purpose of Asonor is to:

“reducing or completely removing strong snoring with the aim to reduce the prevalence of OSA, obstructive sleep apnea.”

The product and its defined purpose is acknowledged by the relevant medical authorities and forms the frame of reference for that particular part of the medical documentation concerning the performance and the link between snoring and OSA. The demands for the authorities are stated below:

  • Classification: We refer to the Directive Article 1, Definitions, Scope (Directive 93/42/EEC)
  • Product safety: We refer to the Annex 1, Essential Requirements (Directive 93/42/EEC)
  • Product performance ( defined purpose ): We refer to Annex 1 and Annex X, Clinical Evaluation (Directive 93/42/EEC)

Outside Europe Asonor® is approved by the medical authorities (Ministry of Health) in more than 70 countries, including USA where Asonor® was registered in 2007.

Asonor® is produced in accordance with the guidelines for production of medicine at GMP facilities in Germany, Spain and Denmark.

There are no known or registered side effects from using Asonor®

In most countries, Asonor® is available as an OTC product and available in leading pharmacies

Asonor is recommended for patients who experience ordinary to heavy snoring. These patients often suffer from tiredness during the day and/or a dry mucous membrane and high blood pressure.

The patient is typically a male over 35 years of age with an unhealthy lifestyle (stress, smoking, alcohol and unhealthy food). Our experience has shown that more and more women are suffering from snoring.

Asonor is the alternative to laser treatment and anti-snoring sleeping devices which are used in the mouth or nose at night. Many of our Asonor users have complained that these devices are uncomfortable.

In addition, there is a certain health risks that laser treatment s pose and also have some side effects, which cannot be treated. Asonor is a widely accepted snoring solution provider.

International research shows that snorers have a decrease in quality of life with a high risk of cardiovascular diseases, high blood pressure, stress, decreased sexual function, obstructive sleep apnoea, headache and premature death. We have linked some of these studies. Read more.

Select your currency
USD United States (US) dollar
EUR Euro